SCHEMBL19207639

SCHEMBL19207639

CN1CCCCC(NC(=O)c2nnc(Cc3ccccc3)[nH]2)C1=O

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.46
RIPK1 Q13546 17/20 0.45
SRC P12931 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19207637 1.00 NAMPT (0.46) NAMPTRIPK1SRC
SCHEMBL18366219 0.81 RIPK1 (0.65) RIPK1
SCHEMBL18371481 0.81 RIPK1 (0.49) RIPK1
SCHEMBL18366236 0.79 RIPK1 (0.67) RIPK1
SCHEMBL23278645 0.79 RIPK1 (0.48) RIPK1
SCHEMBL19255621 0.79 RIPK1 (0.71) RIPK1
SCHEMBL17312381 0.79 RIPK1 (0.71) RIPK1
SCHEMBL17312379 0.79 RIPK1 (0.71) RIPK1
SCHEMBL18366164 0.79 RIPK1 (0.72) RIPK1
SCHEMBL18366161 0.79 RIPK1 (0.72) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414239-A2 INHIBITORS OF RECEPTOR-INTERACTING PROTEIN KINASE 1 Denali Therapeutics Inc. (US) 2018-12-19 EP disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed